Yoshiki Narimatsu

Yoshiki Narimatsu

Auto-generated profile, based on publicly available information

Yoshiki Narimatsu

Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
KSKatrine T. Schjoldager
Katrine T. Schjoldager
YNYoshiki Narimatsu
Yoshiki Narimatsu
HJHiren J. Joshi
Hiren J. Joshi
HCHenrik Clausen
Henrik Clausen

1 July 2019 in Molecular Cell
Verified
Journal Article
Closed access
YNYoshiki Narimatsu
Yoshiki Narimatsu
HJHiren J. Joshi
Hiren J. Joshi
RNRebecca Nason
Rebecca Nason
JCJulie Van Coillie
Julie Van Coillie
RKRichard Karlsson
Richard Karlsson
HCHenrik Clausen
Henrik Clausen

23 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CBChristian Büll
Christian Büll
RNRebecca Nason
Rebecca Nason
LSLingbo Sun
Lingbo Sun
JCJulie Van Coillie
Julie Van Coillie
DSDaniel Madriz Sørensen
Daniel Madriz Sørensen
YNYoshiki Narimatsu
Yoshiki Narimatsu
Siglecs are a family of sialic acid–binding receptors expressed by cells of the immune system and a few other cell types capable of modulating immune cell functions upon recognition of sialoglycan ligands. While human Siglecs primarily bind to sialic acid residues on diverse types of glycoproteins and glycolipids that constitute the sialome, their fine binding specificities for elaborated complex glycan structures and the contribution of the glycoconjugate and protein context for recognition of sialoglycans at the cell surface are not fully elucidated. Here, we generated a library of isogenic human HEK293 cells with combinatorial loss/gain of individual sialyltransferase genes and the introduction of sulfotransferases for display of the human sialome and to dissect Siglec interactions in the natural context of glycoconjugates at the cell surface. We found that Siglec-4/7/15 all have distinct binding preferences for sialylated GalNAc-type O-glycans but exhibit selectivity for patterns of O-glycans as presented on distinct protein sequences. We discovered that the sulfotransferase CHST1 drives sialoglycan binding of Siglec-3/8/7/15 and that sulfation can impact the preferences for binding to O-glycan patterns. In particular, the branched Neu5Acα2–3(6-O-sulfo)Galβ1–4GlcNAc (6′-Su-SLacNAc) epitope was discovered as the binding epitope for Siglec-3 (CD33) implicated in late-onset Alzheimer’s disease. The cell-based display of the human sialome provides a versatile discovery platform that enables dissection of the genetic and biosynthetic basis for the Siglec glycan interactome and other sialic acid–binding proteins. Significance Siglecs are immunomodulatory receptors that recognize sialic acid–carrying glycans with important functions in immunity. However, many of their natural ligands are poorly defined. We generated a cell-based glycan array comprised of a library of isogenic human cells displaying the greater complexity of sialic acids on diverse glycan structures and glycoconjugates in the natural context of the cell surface. We applied this array to reveal fine binding specificities of Siglecs for sialoglycans, informed of the underlying required glycosyltransferase genes, and provided evidence for selective binding context provided by glycan presentation on distinct protein sequences. Insight into the fine binding specificities of Siglecs will advance understanding their diverse biological functions and benefit therapeutic targeting in autoimmunity, inflammation, cancer, and Alzheimer’s disease.

13 August 2018 in Nature Methods
Verified
Journal Article
Closed access
PDF file
YCYen-Hsi Chen
Yen-Hsi Chen
YNYoshiki Narimatsu
Yoshiki Narimatsu
TCThomas M. Clausen
Thomas M. Clausen
CGCatarina Gomes
Catarina Gomes
RKRichard Karlsson
Richard Karlsson
ZYZhang Yang
Zhang Yang

1 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
RNRebecca Nason
Rebecca Nason
CBChristian Büll
Christian Büll
AKAndriana Konstantinidi
Andriana Konstantinidi
LSLingbo Sun
Lingbo Sun
ZYZilu Ye
Zilu Ye
YNYoshiki Narimatsu
Yoshiki Narimatsu
Mucins are a large family of heavily O-glycosylated proteins that cover all mucosal surfaces and constitute the major macromolecules in most body fluids. Mucins are primarily defined by their variable tandem repeat (TR) domains that are densely decorated with different O-glycan structures in distinct patterns, and these arguably convey much of the informational content of mucins. Here, we develop a cell-based platform for the display and production of human TR O-glycodomains (~200 amino acids) with tunable structures and patterns of O-glycans using membrane-bound and secreted reporters expressed in glycoengineered HEK293 cells. Availability of defined mucin TR O-glycodomains advances experimental studies into the versatile role of mucins at the interface with pathogenic microorganisms and the microbiome, and sparks new strategies for molecular dissection of specific roles of adhesins, glycoside hydrolases, glycopeptidases, viruses and other interactions with mucin TRs as highlighted by examples.

16 February 2017 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
LLLindsey A Lonowski
Lindsey A Lonowski
YNYoshiki Narimatsu
Yoshiki Narimatsu
ARAnjum Riaz
Anjum Riaz
CDCatherine E Delay
Catherine E Delay
ZYZhang Yang
Zhang Yang
MFMorten Frödin
Morten Frödin